English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel Journal article
Du,Xiao, Yin,Shaoping, Xu,Linqiang, Ma,Jiqun, Yu,Hua, Wang,Guangji, Li,Juan. Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel[J]. Carbohydrate Polymers, 2020, 229, 115484.
Authors:  Du,Xiao;  Yin,Shaoping;  Xu,Linqiang;  Ma,Jiqun;  Yu,Hua; et al.
Favorite | TC[WOS]:56 TC[Scopus]:65  IF:10.7/10.2 | Submit date：2021/03/02
Bioavailability  Chitosan  Mucoadhesion  Nanoparticle  Oral Delivery  
Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity Conference paper
Zhao, Yuying, Xiong, Sha, Liu, Wei, Liu, Yao, Wang, Qun, Luo, Jingshan, Chen, Xiaojia, Chen, Tonakai. Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity[C], Yantai:The 13th Chinese Pharmaceutical Conference, 2019.
Authors:  Zhao, Yuying;  Xiong, Sha;  Liu, Wei;  Liu, Yao;  Wang, Qun; et al.
Favorite |  | Submit date：2022/08/02
Parkinson's Disease  Peg-pcl Nanoparticles  Ginkgolide b  Oral Bioavailability  Anti-parkinsonian Efficacy  Brain Delivery  
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol by a nanocrystal formulation Conference paper
Xiong, Sha, Liu, Wei, Chen, Xiaojia, Wang, Qi, Yuan, Dongsheng, Chen, Tongkai. Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol by a nanocrystal formulation[C], Guangzhou:The 12th Chinese Pharmaceutical Conference, 2018.
Authors:  Xiong, Sha;  Liu, Wei;  Chen, Xiaojia;  Wang, Qi;  Yuan, Dongsheng; et al.
Favorite |  | Submit date：2022/08/02
Nanocrystals  Resveratrol  Oral Bioavailability  Anti-parkinsonian Efficacy  Parkinson's Disease  
Star-Shaped PLGA nanoparticles of puerarin with sustained release to improve oral bioavailability and anti-Parkinsonian efficacy Conference paper
Chen, Tongkai, Liu, Wei, Xiong, Sha, Chen, Xiaojia, Wang, Qi. Star-Shaped PLGA nanoparticles of puerarin with sustained release to improve oral bioavailability and anti-Parkinsonian efficacy[C], Shanghai:The 3rd International Conference on Nanomedicine, 2018.
Authors:  Chen, Tongkai;  Liu, Wei;  Xiong, Sha;  Chen, Xiaojia;  Wang, Qi
Favorite |  | Submit date：2022/08/02
Star-shaped Plga Nanoparticles  Puerarin  Oral Bioavailability  Brain Delivery  Parkinson's Disease  
Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Ruibing Wang, Simon Ming-Yuen Lee, Ying Zheng. Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity[J]. ACS Applied Materials and Interfaces, 2017, 9(11), 9516-9527.
Authors:  Tongkai Chen;  Chuwen Li;  Ye Li;  Xiang Yi;  Ruibing Wang; et al.
Favorite | TC[WOS]:70 TC[Scopus]:76  IF:8.3/8.7 | Submit date：2018/12/28
Brain Delivery  Cellular Uptake  Fluorescence Resonance Energy Transfer (Fret)  Mpeg−plga Nanoparticles  Oral Bioavailability  Schisantherin a  
Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
Chen, Tongkai, Li, Chuwen, Li, Ye, Yi, Xiang, Wang, Ruibing, Lee, Simon Ming-Yuen, Zheng, Ying. Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity[J]. ACS APPLIED MATERIALS & INTERFACES, 2017, 9(11), 9516-9527.
Authors:  Chen, Tongkai;  Li, Chuwen;  Li, Ye;  Yi, Xiang;  Wang, Ruibing; et al.
Favorite | TC[WOS]:70 TC[Scopus]:76  IF:8.3/8.7 | Submit date：2018/10/30
Brain Delivery  Cellular Uptake  Fluorescence Resonance Energy Transfer (Fret)  Mpeg-plga Nanoparticles  Oral Bioavailability  Schisantherin a  
Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson's disease Journal article
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Simon Ming-Yuen Lee, Ying Zheng. Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson's disease[J]. Molecular Pharmaceutics, 2016, 13(11), 3864-3875.
Authors:  Tongkai Chen;  Chuwen Li;  Ye Li;  Xiang Yi;  Simon Ming-Yuen Lee; et al.
Favorite | TC[WOS]:47 TC[Scopus]:50 | Submit date：2018/11/06
Brain Delivery  Dissolution  Nanocrystals  Oral Bioavailability  Parkinson's Disease (Pd)  
A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals Journal article
Li Y., Sun S., Chang Q., Zhang L., Wang G., Chen W., Miao X., Zheng Y.. A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals[J]. Molecular Pharmaceutics, 2013, 10(7), 2534-2542.
Authors:  Li Y.;  Sun S.;  Chang Q.;  Zhang L.;  Wang G.; et al.
Favorite | TC[WOS]:41 TC[Scopus]:48 | Submit date：2018/12/28
Antisolvent-precipitation  Glycoside  Icaritin (Ict)  Nanocrystal  Oral Bioavailability  Osteoporosis  
Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability Journal article
Yang Z., Tan Y., Chen M., Dian L., Shan Z., Peng X., Wu C.. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability[J]. AAPS PharmSciTech, 2012, 13(4), 1483-1491.
Authors:  Yang Z.;  Tan Y.;  Chen M.;  Dian L.;  Shan Z.; et al.
Favorite | TC[WOS]:77 TC[Scopus]:80 | Submit date：2018/12/27
Amphotericin b  Cubosomes  Oral Bioavailability  Solemuls Technology  
Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound Journal article
Tong H.H.Y., Du Z., Wang G.N., Chan H.M., Chang Q., Lai L.C.M., Chow A.H.L., Zheng Y.. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound[J]. International Journal of Pharmaceutics, 2011, 404(1-2), 148-158.
Authors:  Tong H.H.Y.;  Du Z.;  Wang G.N.;  Chan H.M.;  Chang Q.; et al.
Favorite | TC[WOS]:63 TC[Scopus]:74  IF:5.3/5.6 | Submit date：2018/10/30
Dissolution  Oleanolic Acid  Oral Bioavailability  Sodium Caprate  Sodium Oleanolate  Spray Freeze Drying